Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions

Amy C Engevik1, Alexander W Coutts2, Izumi Kaji1

  • 1Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee; The Epithelial Biology Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

Gastroenterology
|March 1, 2020
PubMed
Abstract

Insights

Microvillus inclusion disease (MVID), a severe infant diarrhea disorder caused by MYO5B gene mutations, now has a large animal model. This pig model mimics human MVID, aiding research into disease mechanisms and potential therapies.

Area of Science:

  • Gastroenterology
  • Genetics
  • Animal Models

Background:

  • Microvillus inclusion disease (MVID) is a rare, life-threatening congenital disorder.
  • It is characterized by severe watery diarrhea starting from birth.
  • Inactivating mutations in the myosin VB (MYO5B) gene are the primary cause of MVID.

Purpose of the Study:

  • To develop a large animal model for studying MVID pathophysiology.
  • To investigate the role of MYO5B in intestinal epithelial cell function.
  • To provide a platform for testing potential MVID treatments.

Main Methods:

  • Gene editing (TALENs) was used to introduce a MYO5B mutation (P663L) in pigs.
  • Cloned pigs carrying the MYO5B mutation were generated.
  • Duodenal tissues and enteroids from affected pigs and human patients were analyzed using immunohistochemistry.

Main Results:

  • Pig MVID model showed MYO5B mislocalization, similar to human patients.
  • Reduced apical levels of sodium hydrogen exchanger 3 (NHE3) and SGLT1 were observed in piglet intestines.
  • Alterations in bile salt export pump (BSEP) expression were noted in the livers of affected piglets.

Conclusions:

  • A large animal model accurately recapitulating key features of human MVID has been successfully developed.
  • This model offers a valuable tool for understanding MYO5B function and MVID pathogenesis.
  • Further studies using this model may lead to the development of novel therapeutic strategies for MVID.